Dose-finding Study of ASP2151 in Subjects With Herpes Zoster
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of three different doses of ASP2151, as compared to
valacyclovir hydrochloride in subjects with herpes zoster, and to determine the recommended
clinical dose.